De Rubertis Francesco
CIK 1601521 · View on SEC EDGAR ↗
First SEC filing: May 27, 2021 · Latest: May 27, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2021 | CNTA | P | 796 | $12.82 | $10,205 | 93,526 Indirect | +0.86% | Acquired | |
| Dec. 2, 2021 | CNTA | P | 33,530 | $12.82 | $429,855 | 3,936,970 Indirect | +0.86% | Acquired | |
| Dec. 1, 2021 | CNTA | P | 1,399 | $12.62 | $17,655 | 92,730 Indirect | +1.53% | Acquired | |
| Dec. 1, 2021 | CNTA | P | 58,905 | $12.62 | $743,381 | 3,903,440 Indirect | +1.53% | Acquired | |
| Nov. 30, 2021 | CNTA | P | 855 | $11.62 | $9,935 | 91,331 Indirect | +0.95% | Acquired | |
| Nov. 30, 2021 | CNTA | P | 35,992 | $11.62 | $418,227 | 3,844,535 Indirect | +0.95% | Acquired | |
| Nov. 29, 2021 | CNTA | P | 1,315 | $11.70 | $15,386 | 90,476 Indirect | +1.47% | Acquired | |
| Nov. 29, 2021 | CNTA | P | 55,391 | $11.70 | $648,075 | 3,808,543 Indirect | +1.48% | Acquired | |
| Nov. 26, 2021 | CNTA | P | 274 | $11.34 | $3,107 | 89,161 Indirect | +0.31% | Acquired | |
| Nov. 26, 2021 | CNTA | P | 11,543 | $11.34 | $130,898 | 3,753,152 Indirect | +0.31% | Acquired | |
| June 2, 2021 | CNTA | P | 13,923 | $20.00 | $278,460 | 88,887 Indirect | +18.57% | Acquired | |
| June 2, 2021 | CNTA | P | 586,077 | $20.00 | $11,721,540 | 3,741,609 Indirect | +18.57% | Acquired | |
| Aug. 10, 2016 | NERV | S | 1,000,000 | $10.00 | $10,000,000 | 4,488,272 Indirect | -18.22% | Disposed | -93.8% (price as of 2026-08-19) |
| March 18, 2015 | NERV | P | 202,634 | $0.12 | $24,316 | 202,634 Indirect | — | Acquired | 415.1% (price as of 2026-08-19) |
| March 18, 2015 | NERV | P | 202,634 | $4.81 | $974,670 | 5,488,272 Indirect | +3.83% | Acquired | -87.1% (price as of 2026-08-19) |
| July 7, 2014 | NERV | P | 333,333 | $6.00 | $1,999,998 | 5,285,638 Indirect | +6.73% | Acquired | -89.7% (price as of 2026-08-19) |
| July 7, 2014 | NERV | P | 1,287,500 | $6.00 | $7,725,000 | 4,952,305 Indirect | +35.13% | Acquired | -89.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 2, 2021 | CNTA | Series A Preferred Shares | Ordinary Shares [F1] (44,828) | — | — | 44,828 | Disposed |
| June 2, 2021 | CNTA | Series A Preferred Shares | Ordinary Shares [F1] (1,886,990) | — | — | 1,886,990 | Disposed |
| Jan. 29, 2021 | CNTA | Series A Preferred Shares | Ordinary Shares [F1] | — | — | 44,828 | Acquired |
| Jan. 29, 2021 | CNTA | Series A Preferred Shares | Ordinary Shares [F1] | — | — | 1,886,990 | Acquired |
| Dec. 12, 2016 | NERV | Warrant Shares | Common Shares | $5.77 | March 18, 2017 | 202,634 | Disposed |
| March 18, 2015 | NERV | Warrant Shares | Common Shares (202,634) | $5.77 | March 18, 2017 | 202,634 | Acquired |
| July 7, 2014 | NERV | Convertible Promissory Note | Convertible Promissory Note (61,922) | — | — | 61,922 | Disposed |
| July 7, 2014 | NERV | Convertible Promissory Note | Convertible Promissory Note (114,077) | — | — | 114,077 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 4,398,519 | Indirect |
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 55,677 | Indirect |
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 1,268,542 | Indirect |
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 30,136 | Indirect |
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 9,403,092 | Indirect |
| May 27, 2021 | CNTA | Ordinary Shares [F1,F2] | 236,108 | Indirect |
| May 27, 2021 | CNTA | Series A Preferred Shares→ Ordinary Shares [F2] (1,886,990) | 1,886,990 | Indirect |
| May 27, 2021 | CNTA | Series A Preferred Shares→ Ordinary Shares [F2] (44,828) | 44,828 | Indirect |
| June 30, 2014 | NERV | Common Stock | 3,436,898 | Indirect |
| June 30, 2014 | NERV | Convertible Promissory Notes→ Common Stock (113,891) | 113,891 | Indirect |
| June 30, 2014 | NERV | Convertible Promissory Notes→ Common Stock (61,913) | 61,913 | Indirect |